Affymetrix Inc. has announced that it has launched the GeneChip® Array Station, an automated target preparation and microarray processing system that is designed to increase accuracy and lower the ...

SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix, Inc. (NASDAQ:AFFX) today announced that the U.S. Food and Drug Administration has cleared the addition of new gene expression reagents as accessories ...

Rosetta Biosoftware has announced that the Rosetta Syllego™ system has achieved GeneChip-compatible™ status for use with the Affymetrix microarray platform. This compatibility enables research ...

Kits will be configured for use with the GeneChip System 3000Dx v.2. Asuragen is to develop and manufacture RNA Control Kits for Affymetrix for use with its in vitro transcription reagent kits for ...

At first glance, the luminous image rolling across a conference room wall at Affymetrix Inc. looks like mysterious transmissions from an alien race using an intricate language we don't understand. But ...

We’ll also continue to sell the GeneChip system on the diagnostic side to many customers as well, so that product will continue to go forward. Doug Schenkel - Cowen and Company Panomics is an RNA ...

Agencourt Bioscience, a wholly-owned subsidiary of Beckman Coulter (BEC), NuGEN Technologies, and Affymetrix Clinical Services Laboratory announce a collaboration that has yielded a service offering ...

NEW YORK (CBS.MW) -- Affymetrix Inc. said Monday the U.S. Food and Drug Administration has approved its GeneChip system 3000Dx, an instrumentation system to analyze in vitro diagnostic microarrays.

Affymetrix, Inc. and DNA Link, Inc., a Korean genomics-based biotechnology company, have signed a Powered by Affymetrix (PbA) Programme agreement in which DNA Link, Inc. obtains a worldwide license to ...

Microarrays have been widely used for the analysis of gene expression, but the issue of reproducibility across platforms has yet to be fully resolved. To address this apparent problem, we compared ...